Treatment of patients with peripheral arterial occlusive disease fontaine stage IV with intravenous iloprost and PGE1: A randomized open controlled study-Reference-Cited by-同舟云学术

Treatment of patients with peripheral arterial occlusive disease fontaine stage IV with intravenous iloprost and PGE1: A randomized open controlled study

Published:1993-08 Issue:2 Volume:49 Page:573-578
ISSN:0952-3278
Container-title:Prostaglandins, Leukotrienes and Essential Fatty Acids
language:en
Short-container-title:Prostaglandins, Leukotrienes and Essential Fatty Acids

Author:

Altstaedt H.O.,Berzewski B.,Taschke C.

Publisher

Elsevier BV

Subject

Cell Biology,Clinical Biochemistry

Reference21 articles.

1. The definition of critical ischaemia — is this a concept of value?;Wolfe,1988

2. Second European Consensus Document on Chronic Critical Leg Ischaemia;Circulation,1991

3. Defining the outcome of critical ischaemia: A one year pro-spective study;Wolfe;Br J Surg,1986

4. Die PTA in den Stadien III und IV der peripheren arteriellen Verschlußkrankheit;Schneider;Vasa,1980

5. Prostaglandin E1 in der therapie der peri-pheren arteriellen Durchblutungsstörung;Sinzinger;Wien Klin Wochenschr,1991

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Beneficial effects of alprostin in patients with critical limb ischemia with peripheral arterial disease: A retrospective study;Indian Journal of Vascular and Endovascular Surgery;2022

2. ESVM Guideline on peripheral arterial disease;Vasa;2019-12

3. Prostanoids for Critical Limb Ischemia: A Clinical Review and Consideration of Current Guideline Recommendations;Angiology;2019-11-26

4. Alprostadil treatment of critical limb ischemia in hemodialysis patients;Wiener klinische Wochenschrift;2018-11-12

5. Prostanoids for critical limb ischaemia;Cochrane Database of Systematic Reviews;2018-01-10